Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11673457rdf:typepubmed:Citationlld:pubmed
pubmed-article:11673457lifeskim:mentionsumls-concept:C0598783lld:lifeskim
pubmed-article:11673457lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:11673457lifeskim:mentionsumls-concept:C1704735lld:lifeskim
pubmed-article:11673457lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:11673457lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:11673457pubmed:issue2lld:pubmed
pubmed-article:11673457pubmed:dateCreated2002-1-7lld:pubmed
pubmed-article:11673457pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:abstractTextPeroxisomes function in beta-oxidation of very long and long-chain fatty acids, dicarboxylic fatty acids, bile acid intermediates, prostaglandins, leukotrienes, thromboxanes, pristanic acid, and xenobiotic carboxylic acids. These lipids are mainly chain-shortened for excretion as the carboxylic acids or transported to mitochondria for further metabolism. Several of these carboxylic acids are slowly oxidized and may therefore sequester coenzyme A (CoASH). To prevent CoASH sequestration and to facilitate excretion of chain-shortened carboxylic acids, acyl-CoA thioesterases, which catalyze the hydrolysis of acyl-CoAs to the free acid and CoASH, may play important roles. Here we have cloned and characterized a peroxisomal acyl-CoA thioesterase from mouse, named PTE-2 (peroxisomal acyl-CoA thioesterase 2). PTE-2 is ubiquitously expressed and induced at mRNA level by treatment with the peroxisome proliferator WY-14,643 and fasting. Induction seen by these treatments was dependent on the peroxisome proliferator-activated receptor alpha. Recombinant PTE-2 showed a broad chain length specificity with acyl-CoAs from short- and medium-, to long-chain acyl-CoAs, and other substrates including trihydroxycoprostanoyl-CoA, hydroxymethylglutaryl-CoA, and branched chain acyl-CoAs, all of which are present in peroxisomes. Highest activities were found with the CoA esters of primary bile acids choloyl-CoA and chenodeoxycholoyl-CoA as substrates. PTE-2 activity is inhibited by free CoASH, suggesting that intraperoxisomal free CoASH levels regulate the activity of this enzyme. The acyl-CoA specificity of recombinant PTE-2 closely resembles that of purified mouse liver peroxisomes, suggesting that PTE-2 is the major acyl-CoA thioesterase in peroxisomes. Addition of recombinant PTE-2 to incubations containing isolated mouse liver peroxisomes strongly inhibited bile acid-CoA:amino acid N-acyltransferase activity, suggesting that this thioesterase can interfere with CoASH-dependent pathways. We propose that PTE-2 functions as a key regulator of peroxisomal lipid metabolism.lld:pubmed
pubmed-article:11673457pubmed:languageenglld:pubmed
pubmed-article:11673457pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:citationSubsetIMlld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11673457pubmed:statusMEDLINElld:pubmed
pubmed-article:11673457pubmed:monthJanlld:pubmed
pubmed-article:11673457pubmed:issn0021-9258lld:pubmed
pubmed-article:11673457pubmed:authorpubmed-author:HuntMary CMClld:pubmed
pubmed-article:11673457pubmed:authorpubmed-author:AlexsonStefan...lld:pubmed
pubmed-article:11673457pubmed:authorpubmed-author:SolaasKariann...lld:pubmed
pubmed-article:11673457pubmed:authorpubmed-author:KaseB FrodeBFlld:pubmed
pubmed-article:11673457pubmed:issnTypePrintlld:pubmed
pubmed-article:11673457pubmed:day11lld:pubmed
pubmed-article:11673457pubmed:volume277lld:pubmed
pubmed-article:11673457pubmed:ownerNLMlld:pubmed
pubmed-article:11673457pubmed:authorsCompleteYlld:pubmed
pubmed-article:11673457pubmed:pagination1128-38lld:pubmed
pubmed-article:11673457pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:meshHeadingpubmed-meshheading:11673457...lld:pubmed
pubmed-article:11673457pubmed:year2002lld:pubmed
pubmed-article:11673457pubmed:articleTitleCharacterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism.lld:pubmed
pubmed-article:11673457pubmed:affiliationDepartment of Medical Laboratory Sciences and Technology, Division of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, SE-141 86 Stockholm, Sweden. mary.hunt@chemlab.hs.sll.selld:pubmed
pubmed-article:11673457pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11673457pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:170789entrezgene:pubmedpubmed-article:11673457lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11673457lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11673457lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11673457lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11673457lld:pubmed